Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain
Susan E. Krown(Memorial Sloan Kettering Cancer Center), Donna Niedzwiecki(Duke University), Frank G. Haluska(Ariadne Diagnostics (United States)), Wen‐Jen Hwu(The University of Texas MD Anderson Cancer Center), Lydia Hodgson(Duke Medical Center), Alan N. Houghton(Eastern Cooperative Oncology Group)
Cited by 63
Related Papers
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
|Journal of Clinical Oncology|2010|840
Analysis of human transcriptomes
|Nature Genetics|1999|789
Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma
|Journal of Clinical Oncology|1999|763
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707